ADMA EPS Estimates
ADMA Biologics, Inc.
$13.68
+$0.44(+3.32%)
70
Overall
70
Value
75
Tech
65
Quality
Market Cap
$3.03B
Volume
4.16M
52W Range
$7.21 - $20.46
Target Price
$16.40
ADMA EPS estimates: the consensus estimate for ADMA Biologics, Inc.'s current fiscal year is $0.82 per share. Quarterly and next-year EPS forecasts, growth estimates and revenue projections follow.
ADMA EPS Estimates
- EPS estimate, current quarter
- $0.22
- EPS estimate, next quarter
- $0.16
- EPS estimate, current year
- $0.82
- EPS estimate, next year
- $0.86
- EPS growth, 3-year
- +57.12%
| Fiscal year | EPS |
|---|---|
| 2025 | $0.62 |
| 2024 | $0.85 |
| 2023 | $-0.13 |
| 2022 | $-0.33 |
| 2021 | $-0.51 |
| A | B | C | D | |
|---|---|---|---|---|
| 1 | Symbol | Price | Change | Vol |
| 2 | ADMA | $13.68 | +3.3% | 4.16M |
| 3 | ||||
| 4 | ||||
| 5 | ||||
| 6 |